|
|
|
| Effects of siRNAs targeting CD97 immune epitopes on biological behavior in breast cancer cell line MDA-MB231 |
| TIAN Hua, CHEN Yang, ZHAO Jiangang, LIU Daren, LIANG Gang, GONG Weihua, CHEN Li, WU Yulian |
| Department of General Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China |
|
|
|
Abstract Objective:To investigate the effects of siRNAs targeting CD97 immune epitopes on proliferation, infiltration, apoptosis and cell cycle of breast cancer cells. Methods:siRNA sequences targeting CD97EGF and CD97Stalk immune epitopes were designed according to Gene Bank NM_001025160.2 with smart siCatchTM siRNA design software. CD97siRNAs were transfected into MDA-MB231 cells in which CD97 was highly expressed. Highest sensitive CD97EGF and CD97Stalk siRNA were screened by Western blotting. Inverted microscope was used to observe the growth of CD97siRNAs-transfected MDA-MB231 cells; the proliferation activity of MDA-MB231 cells was detected by MTT method; the wound healing assay and Transwell migration test were performed to examine the migration and infiltration ability of CD97EGF and CD97Stalk siRNA-transfected MDA-MB231 cells; the effects of CD97EGF siRNA and CD97Stalk siRNA on cell apoptosis and cell cycle of MDA-MB231 cells were detected by TUNEL and flow cytometry. Results:The growth and proliferation activity of CD97siRNAs-transfected MDA-MB231 cells were significantly lower than those in the control groups, and such differences were more significant in CD97Stalk siRNA-transfected group (all P<0.05); scratch test showed that the wound healing rate was lower in CD97siRNAs-transfected groups, especially in CD97Stalk siRNA-transfected group (all P<0.05); Transwell migration showed that the number of MDA-MB231 cells crossing through chambers were less in CD97siRNAs-transfected groups, especially in CD97Stalk siRNA-transfected group (all P<0.05); no significant difference in cell apoptosis was observed between CD97siRNAs-transfected groups and control groups; cell cycle detection showed that CD97siRNAs-transfected groups had less cells in G0/G1 phase and more cells in S phase compared with the control groups, and such effect on cell cycle was more marked in CD97Stalk siRNA-transfected group (all P<0.05). Conclusion:CD97 plays an important role in the cell growth, proliferation, migration and invasion of breast cancer MDA-MB231 cells, and compared with CD97EGF, CD97Stalk may have more effective inhibitory effects on cellular malignant behaviors.
|
|
Received: 10 April 2017
Published: 25 August 2017
|
|
|
CD97免疫表位对乳腺癌细胞株MDA-MB231生物学行为的影响
目的：明确CD97免疫表位CD97EGF和CD97Stalk对乳腺癌细胞生物学行为的影响。方法：采用siCatchTM siRNA design软件设计CD97EGF小干扰RNA（siRNA）和CD97Stalk siRNA并转染CD97高表达乳腺癌细胞株MDA-MB231；蛋白质印迹法筛选高敏感CD97EGFsiRNA和CD97Stalk siRNA。倒置显微镜观察和计数siRNA转染后乳腺癌细胞的生长；四唑盐（MTT）法检测siRNA转染后乳腺癌细胞的增殖活性；划痕试验和Transwell试验观察siRNA转染对乳腺癌细胞迁移和侵袭力的影响；TUNEL法检测siRNA转染对乳腺癌细胞凋亡的影响；流式细胞术检测siRNA转染对乳腺癌细胞周期的影响。结果：siRNA转染后，乳腺癌细胞的生长数量和增殖活性明显低于对照组，且CD97Stalk siRNA组的变化较CD97EGFsiRNA组更为显著（均P<0.05）；划痕试验结果显示，siRNA转染组乳腺癌细胞的移动速率明显慢于对照组（均P<0.01），且CD97Stalk siRNA对乳腺癌细胞移动速率的影响明显大于CD97EGFsiRNA（P<0.05）；Transwell试验结果显示，siRNA转染组迁移过膜的细胞数量明显少于对照组，且以CD97Stalk siRNA组减少最为显著（均P<0.05）。siRNA转染对乳腺癌细胞凋亡率的影响不明显，但siRNA转染组中G0/G1期细胞所占比例较对照组明显减小，而S期细胞所占的比例明显增加，且CD97Stalk siRNA对细胞周期的影响较CD97EGFsiRNA更为显著（均P<0.05）。结论：CD97蛋白分子可能参与乳腺癌细胞株的生长、增殖、迁移和侵袭等生物学行为，CD97Stalk免疫表位对于乳腺癌细胞株生物学行为影响较CD97EGF免疫表位更为显著。
关键词：
RNA,
小分子干扰,
乳腺肿瘤/病理学,
抗原,
CD,
细胞凋亡,
细胞周期,
细胞增殖,
肿瘤浸润,
表位
|
|
| [1] MUNK C, ISBERG V, MORDALSKI S, et al. GPCRdb:the G protein-coupled receptor database-an introduction[J]. Br J Pharmacol,2016,173(14):2195-2207.
[2] PIERCE K L, PREMONT R T, LEFKOWITZ R J. Seven-transmembrane receptors[J]. Nat Rev Mol Cell Biol,2002,3(9):639-650.
[3] NIJMEIJER S, VISCHER H F, LEURS R. Adhesion GPCRs in immunology[J]. Biochem Pharmacol,2016,114:88-102.
[4] LIU D, TROJANOWICZ B, RADESTOCKY, et al. Role of CD97 isoforms in gastric carcinoma[J]. Int J Oncol,2010,36(6):1401-1408.
[5] HOANG-VU C, BULL K, SCHWARZI, et al. Regulation of CD97 protein in thyroid carcinoma[J]. J Clin Endocrinol Metab,1999,84(3):1104-1109.
[6] WOBUS M, VOGEL B, SCHMVCKING E, et al. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding[J]. Int J Cancer,2004,112(5):815-822.
[7] 袁晓雷,田华,朱旭明,等.CD97-CD55蛋白复合体在乳腺恶性肿瘤组织中的表达及临床意义[J].浙江医学,2014,36(11):928-936. YUAN Xiaolei, TIAN Hua, ZHU Xuming, et al. Expression of CD97-CD55 protein complex in patients with breast malignant tumors and its clinicopathological significance[J]. Zhejiang Medical Journal,2014,36(11):928-936. (in Chinese)
[8] CHEN X, DUAN N, ZHANG C, et al. Survivin and tumorigenesis:molecular mechanisms and therapeutic strategies[J]. J Cancer,2016,7(3):314-323.
[9] HANAHAN D, WEINBERGR A. Hallmarks of cancer:the next generation[J]. Cell,2011,144(5):646-674.
[10] KRISHNA P S, NAGARE R P, SNEHA V S, et al. Tumour angiogenesis-origin of blood vessels[J]. Int J Cancer,2016,139(4):729-735.
[11] GUIDO C, WHITAKER-MENEZES D, CAPPARELLI C, et al. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth:connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production[J]. Cell Cycle,2012,11(16):3019-3035.
[12] YU J S, CUI W. Proliferation, survival and metabolism:the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination[J]. Development,2016,143(17):3050-3060.
[13] GORDON S, HAMANN J, LIN H H, et al. F4/80 and the related adhesion-GPCRs[J]. Eur J Immunol,2011,41(11):2472-2476.
[14] SAFAEE M, CLARK A J, IVAN M E, et al. CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers (Review)[J]. Int J Oncol,2013,43(5):134313-50.
[15] HSIAO C C, CHENG K F, CHEN H Y, et al. Site-specific N-glycosylation regulates the GPS auto-proteolysis of CD97[J]. FEBS Lett,2009,583(19):3285-3290. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
